<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <mixed-citation publication-type="other">Hung IF, Lung K, Tso EY, Liu R, Chung TW, Chu M, et al. Triple combination of interferon beta-1b , lopinavir–ritonavir , and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label , randomised , phase 2 trial. Lancet. 2020:1–10.</mixed-citation>
</ref>
